CA2255101C - Immunoreactive regions of glycoprotein gpii of varicella zoster virus (vzv) - Google Patents

Immunoreactive regions of glycoprotein gpii of varicella zoster virus (vzv) Download PDF

Info

Publication number
CA2255101C
CA2255101C CA002255101A CA2255101A CA2255101C CA 2255101 C CA2255101 C CA 2255101C CA 002255101 A CA002255101 A CA 002255101A CA 2255101 A CA2255101 A CA 2255101A CA 2255101 C CA2255101 C CA 2255101C
Authority
CA
Canada
Prior art keywords
vzv
gpii
leu
zoster virus
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002255101A
Other languages
English (en)
French (fr)
Other versions
CA2255101A1 (en
Inventor
Markus Eickmann
Dorothee Gicklhorn
Klaus Radsak
Hans-Peter Hauser
Bernhard Giesendorf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Products GmbH
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Publication of CA2255101A1 publication Critical patent/CA2255101A1/en
Application granted granted Critical
Publication of CA2255101C publication Critical patent/CA2255101C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002255101A 1997-12-23 1998-12-16 Immunoreactive regions of glycoprotein gpii of varicella zoster virus (vzv) Expired - Fee Related CA2255101C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19757767.9 1997-12-23
DE19757767A DE19757767A1 (de) 1997-12-23 1997-12-23 Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)

Publications (2)

Publication Number Publication Date
CA2255101A1 CA2255101A1 (en) 1999-06-23
CA2255101C true CA2255101C (en) 2009-06-16

Family

ID=7853319

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002255101A Expired - Fee Related CA2255101C (en) 1997-12-23 1998-12-16 Immunoreactive regions of glycoprotein gpii of varicella zoster virus (vzv)

Country Status (7)

Country Link
US (2) US6414116B1 (enExample)
EP (1) EP0927760B1 (enExample)
JP (1) JP4163799B2 (enExample)
AT (1) ATE453715T1 (enExample)
CA (1) CA2255101C (enExample)
DE (2) DE19757767A1 (enExample)
ES (1) ES2341061T3 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19757767A1 (de) * 1997-12-23 1999-07-15 Dade Behring Marburg Gmbh Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)
JP2001074333A (ja) 1999-09-03 2001-03-23 Daikin Ind Ltd ヒートポンプ
CN1989789A (zh) * 2004-07-21 2007-06-27 皇家飞利浦电子股份有限公司 用于气体放电灯的多脉冲点火电路
US12569553B2 (en) 2020-03-09 2026-03-10 Dynavax Technologies Corporation Shingles vaccines comprising a TLR9 agonist

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717772A (en) 1971-09-03 1973-02-20 Midland Capital Corp Linear bidirectional scanning system
US4686101A (en) * 1985-08-02 1987-08-11 Merck & Co., Inc. Vaccine against varicella-zoster virus
ATE116860T1 (de) * 1988-08-01 1995-01-15 Akzo Nobel Nv Pseudorabiesvirus-impfstoff.
ATE119939T1 (de) 1989-06-27 1995-04-15 Smithkline Beecham Biolog Verbindungen.
JPH07199A (ja) * 1993-06-18 1995-01-06 Teijin Ltd 水痘帯状疱疹ウイルス検出用プライマーセット及びそれを用いる同ウイルスの検出方法
DE19757767A1 (de) * 1997-12-23 1999-07-15 Dade Behring Marburg Gmbh Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)

Also Published As

Publication number Publication date
JPH11248710A (ja) 1999-09-17
DE59814427D1 (de) 2010-02-11
US6414116B1 (en) 2002-07-02
ATE453715T1 (de) 2010-01-15
EP0927760A3 (de) 2000-10-11
EP0927760B1 (de) 2009-12-30
CA2255101A1 (en) 1999-06-23
DE19757767A1 (de) 1999-07-15
EP0927760A2 (de) 1999-07-07
ES2341061T3 (es) 2010-06-14
US20020150889A1 (en) 2002-10-17
US6960442B2 (en) 2005-11-01
JP4163799B2 (ja) 2008-10-08

Similar Documents

Publication Publication Date Title
Li et al. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells
Malone et al. Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins
Crabb et al. Epitopes of glycoprotein G of equine herpesviruses 4 and 1 located near the C termini elicit type-specific antibody responses in the natural host
EP0236145B1 (en) Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor
EP0802979B1 (en) Secreted viral cmv proteins useful for vaccines and diagnostics
EP0917576A1 (en) Anti-herpesviral agents and assays therefor
Chang et al. Properties of the protein encoded by the UL32 open reading frame of herpes simplex virus 1
AU732254B2 (en) A human cytomegalovirus combined antigen and its use
US5965354A (en) Herpes simplex virus diagnostics
EP0769056B1 (en) NON-SPLICING VARIANTS OF gp350/220
US6414116B1 (en) Immunoreactive regions of glycoprotein GPII of varicella zoster virus
US6162620A (en) Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor
CA2255106C (en) Varicella zoster virus (vzv) immunoreactive protein vp26 and its diagnostic use
Haanes et al. Genomic organization of the canine herpesvirus US region
AU746231B2 (en) Reagent for detecting and monitoring viral infections
Liu et al. Cloning and expression of a cDNA encoding the Epstein-Barr virus thymidine kinase gene
JPH05276942A (ja) 修飾された１型ウシヘルペスウイルスに基づくワクチン
Furuno et al. Monkey B-lymphotropic papovavirus DNA: nucleotide sequence of the region around the origin of replication
Parker et al. Structural, functional, and immunological characterization of bovine herpesvirus-1 glycoprotein gl expressed by recombinant baculovirus
EP0362288A1 (en) EXPRESSION OF IMMUNOLOGICALLY ACTIVE PROTEINS FROM HUMAN B-LYMPHOTROPIC VIRUS.
IE912291A1 (en) Antigen
CA2246802C (en) A human cytomegalovirus combined antigen and its use
Eiffert et al. Expression of an antigenic polypeptide of the human parvovirus B19
Filfili Production of B Virus Glycoprotein D and Evaluation of its Diagnostic Potential

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20121217